why choose us

First received: April 26, 2024

Clinical Trial: Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Study Type: OBSERVATIONAL


Official Title: Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Brief Summary: This study will examine the clinical effectiveness of Tafamidis in patients with Mixed Phenotype Transthyretin Amyloidosis using data that already exist in patients' medical records

Read more